rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
1996-6-12
|
pubmed:abstractText |
Bcl-xs is a dominant negative repressor of Bcl-2 and Bcl-xL, both of which inhibit apoptosis. We used a replication-deficient adenoviral vector to transiently overexpress Bcl-xs in MCF-7 human breast cancer cells, which overexpress Bcl-xL. Infection with this vector induced apoptosis in vitro. We then determined the effects of intratumoral injection of bcl-xs adenovirus on solid MCF-7 tumors in nude mice. Tumors injected four times with the bcl-xs adenovirus showed a 50% reduction in size. Using terminal transferase-mediated dUTP-digoxigenin nick end labeling, we observed apoptotic cells at sites of bcl-xs adenoviral injection. These experiments demonstrate the feasibility of using bcl-xs gene therapy to induce apoptosis in human breast tumors.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-5472
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1965-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8616832-Animals,
pubmed-meshheading:8616832-Apoptosis,
pubmed-meshheading:8616832-Female,
pubmed-meshheading:8616832-Gene Therapy,
pubmed-meshheading:8616832-Gene Transfer Techniques,
pubmed-meshheading:8616832-Humans,
pubmed-meshheading:8616832-Mammary Neoplasms, Experimental,
pubmed-meshheading:8616832-Mice,
pubmed-meshheading:8616832-Mice, Nude,
pubmed-meshheading:8616832-Neoplasm Transplantation,
pubmed-meshheading:8616832-Proto-Oncogene Proteins,
pubmed-meshheading:8616832-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:8616832-bcl-X Protein
|
pubmed:year |
1996
|
pubmed:articleTitle |
bcl-xs gene therapy induces apoptosis of human mammary tumors in nude mice.
|
pubmed:affiliation |
Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor 48109-0724, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|